well as GCH were examined in the cells after exposure to IL-13. Results: Incubation with IL-13 for 14 and 21 days increased the total number of epithelial cells, the number of periodic acid-Schiff (PAS)-stained epithelial cells, the number of goblet cells, as well as expression of mRNA and protein of hCLCA1 and MUC5AC. The number of goblet cells with secretory granules also increased after 21 days of incubation with IL-13. Nifl umic acid, a chloride channel inhibitor, reduced mRNA expression of hCLCA1 and MUC5AC, and reduced the number of PAS-positive cells after incubation with IL-13. NHBE cells exposed or not to IL-13 expressed IL-13 receptor ␣ 1 (IL-13R ␣ 1 ), and an antibody to IL-13 R ␣ 1 also reduced the number of PASpositive cells after exposure to IL-13. Conclusions: IL-13 might induce the expression of MUC5AC and hCLCA1 gene and protein in well-differentiated NHBE cells. These cells might also differentiate into goblet cells and become hyperplastic.
Introduction
Goblet cell metaplasia and hyperplasia in airways are associated with persistent airway infl ammation. These conditions probably represent an innate host defense to enhance mucus clearance and remove harmful stimuli from the lungs [1, 2] . On the other hand, goblet cell hyperplasia (GCH) is a pathophysiological feature of respiratory diseases characterized by mucus overproduction, such as chronic obstructive pulmonary disease (COPD), asthma, cystic fi brosis and bronchiectasis [3] . Mucus hypersecretion induces obstruction of the peripheral airways in patients with asthma [3] and in patients with diffuse panbronchiolitis [4] , and is a major cause of death among patients with severe asthma [3] .
Interleukin (IL)-13 is the pleiotropic 12-kDa protein product of a gene on chromosome 5 at q31 that is produced in large quantities from activated CD4+ Th2 cells by various antigens [5, 6] . This cytokine plays an important role in airway infl ammation in allergic and non-allergic asthma, as well as in COPD [5, 7, 8] , and it shares a receptor component and signaling pathway with IL-4 [5, 7] . The administration of IL-13 to the mouse trachea induces eosinophil infl ux into the airways, GCH with mucus hypersecretion and airway hyperreactivity [7] . IL-13 transgenic mice also develop airway epithelial hypertrophy, mucus hypersecretion and GCH [9] . Furthermore, a study in vitro has shown that IL-13 induces tracheal epithelial cells to differentiate into mature goblet cells with the production of MUC5AC protein in guinea pigs [10] . Atherton et al. [11] reported that IL-13 induces GCH and MUC5AC protein production in normal human bronchial epithelial (NHBE) cells. Their results suggest that IL-13 directly acts on airway epithelial cells to induce GCH.
Chloride channels of airway epithelial cells play an important role in the regulation of mucus production as well as in airway fl uid and electrolyte transport [12, 13] . Among a novel family of proteins that mediates Ca 2+ -activated conductance (Ca 2+ -activated Cl -channel family; CLCA family), human CLCA1 (hCLCA1) protein is expressed in the digestive tract including the small intestine, colon and appendix [14] . This protein plays an important role in fl uid and electrolyte transport as well as in mucus secretion [14] . Nakanishi et al. [15] have demonstrated that murine gob-5 , corresponding to hCLCA1, is expressed at high levels and strictly localizes in airway epithelium, especially in mucus-producing cells in mice sensitized with ovalbumin. Furthermore, adenoviral gene transfer with an antisense gob-5 construct suppresses the development of airway hyperreactivity and mucus overproduction in ovalbumin-sensitized mice. In contrast, the overexpression of gob-5 in airway epithelia transfected with a sense gob-5 construct via an adenoviral vector results in mucus overproduction and airway hyperreactivity. The expression of hCLCA1 is increased in the epithelial cells of patients with asthma [16] and COPD [17] and in sputum from patients with COPD [17] . A gene transfection study by Kuperman et al. [18] showed that mucus production and murine Muc5ac and Gob-5 expression are induced by IL-13 in Stat6+/-mice. In this manner, both MUC5AC and hCLCA1 induced by IL-13 would participate in GCH of the airway epithelium. However, the relationships between these two genes and protein expression induced by IL-13 in human airway epithelium remain obscure.
The present study examines whether IL-13 directly induces the expression of hCLCA1 and MUC5AC in cultured NHBE cells and investigates the relationship between GCH and the expression of hCLCA1 and MUC5AC.
Materials and Methods

NHBE Cell Culture
Bronchi were obtained from 20 patients (mean age, 64 8 3.1 years; range, 35-77 years) who underwent lung resection due to lung cancer or benign lung tumors. The Ethics Committee of the Shinshu University School of Medicine approved the study, and the patients provided written informed consent to participate in all aspects of the investigation. We isolated and cultured NHBE cells as described by Yamaya et al. [19] and Gray et al. [20] . Briefl y, bronchi were rinsed in ice-cold sterile phosphate-buffered saline (PBS) to remove mucus and debris, and then incubated at 37 ° C for 4-6 h in a 1: 1 mixture of Dulbecco's modifi ed Eagle's medium (DMEM; Sigma, St. Louis, Mo., USA) and Ham's F-12 (F-12; Sigma) containing protease (Dispase, GIBCO, Grand Island, N.Y., 0.1 mg/ml) and 1% antibiotic-antimycotic (GIBCO). After the incubation, the medium was aspirated, and DMEM/F-12 containing 1% antibiotic-antimycotic (DMEM/F12 basic medium) was applied to inhibit the enzyme activity. The bronchi were opened longitudinally in ice-cold DMEM/F12 basic medium, rubbed with blunt-tipped tweezers, and then clusters of NHBE cells were dispersed by repeated aspiration using a 10-ml pipette. Suspended NHBE cells were sedimented at 400 g for 5 min, and then resuspended in DMEM/F-12 basic medium. After counting using a hemocytometer and estimating viability by trypan blue staining, the NHBE cells were seeded at a density of 5 ! 10 Mass., USA) coated with type IV collagen (Cellgen, Koken, Tokyo, Japan), and then cultured in serum-free DMEM/F12 medium containing ITS-A (1.0%; GIBCO), triiodothyronine (10 ng/ml; ICN, Irvine, Calif., USA), epidermal growth factor (EGF; recombinant human EGF, 0.5 ng/ml; GIBCO), all-trans retinoic acid (10 -7 M ;
Wako, Osaka, Japan), hydrocortisone (0.5 g/ml; Wako), bovine serum albumin (2.0 g/ml; Itoham Foods, Hyogo, Japan), endothelial cell growth supplement (8.34 g/ml; UBI, Lake Placid, N.Y., USA) and antibiotic-antimycotic (1.0%; GIBCO). Culture medium was added to both the apical and basolateral side of the inserts, and the cells were cultured by immersed feeding [19] . The culture medium was changed every 2 days. Confl uence was reached within 5 days and then the cells were cultured using an air-liquid interface [19] . Briefl y, the apical medium was removed and cells were nourished only from the basolateral side. The culture medium was changed every 2 days, and the cells were maintained in an incubator under a humidifi ed 5% CO 2 atmosphere at 37 ° C.
Culture with IL-13
When the cells reached confl uence (day 0) as described above, air-liquid interface culture was started. Medium containing IL-13 (0.1, 1, 10 and 100 ng/ml recombinant human IL-13, Biotec, Hamburg, Germany) or vehicle (PBS) was added to the basolateral side of the inserts. The culture medium was changed every 2 days, and cells were incubated for 14 or 21 days (from day 0 to day 14 or day 21) with IL-13 or vehicle (PBS). IL-13 at the concentrations applied here is effective but not toxic [11, [21] [22] [23] .
Real-Time Quantitative PCR
Sample preparation for real-time-quantitative PCR of cultured NHBE cells was examined as described [24] , with some modifi cation. To examine the time course of mRNA expression of hCLCA1 and MUC5AC, RNA was extracted from the cells after 1, 3, 5, 7, 14 or 21 days in the presence of IL-13. The apical side of the cell sheets on Transwell ® culture inserts were gently washed three times with PBS. Total RNA from cultured NHBE cells was extracted using Isogen (Nippon Gene, Tokyo, Japan) according to the manufacturer's instructions. Because the culture insert was too small to contain 1,000 l of Isogen per sample, fi rstly 150 l of Isogen were added to the culture insert and repeatedly pipetted. Thereafter, 150 l of samples were mixed with 850 l of Isogen in centrifuge tubes.
Real-time quantitative PCR proceeded as reported [15, 16] , with some modifi cation. Briefl y, cDNA samples corresponding to 20 ng of total RNA were measured by real-time quantitative PCR using a Perkin-Elmer Applied Biosystems Prism model 7900 sequence detection instrument according to the manufacturer's instructions. Matching primers and TaqMan probes were designed for each of the genes: hCLCA1, ACCTTGACCCTGACTGTCAC-GT (forward primer), GTCCTTGTTCGTTTTGGAAGTCAC (reverse primer) and CGTCCAATGCTACCCTGCCTCCAAT-TAC (TaqMan probe; AF039400) [16] , and MUC5AC, TACTC-CACAGACTGCACCAACTG (forward primer), CGTGTATT-GCTTCCCGTCAA (reverse primer) and TGTGCTTGGAGGT-GCCCACTTCTCAA (TaqMan probe; AF015521) [16] . The reporter and quencher dyes for all probes were 6-carboxyfl uorescein (FAM) and 6-carboxytetramethylrhodamine (TAMRA), respectively. Gene expression levels of hCLCA1 and MUC5AC were compared using the comparative Ct method (Ct = threshold cycle) against the GAPDH gene [25] .
Histochemical Analysis GCH in cultured NHBE cells was histologically examined as described [10] . The cells were fi xed in 20% formalin neutral buffer, embedded in paraffi n and cut into 3-m slices. Mucin production was confi rmed by periodic acid-Schiff (PAS) staining. We compared the differentiation of NHBE cells incubated with vehicle or IL-13 into goblet cells as follows. Goblet cell density was analyzed according to the method described by Atherton et al. [11] , with some modifi cation. The numbers of total epithelial cells, PAS-positive cells and goblet cells were measured by counting epithelial nuclei over 250 m in fi ve random sites per specimen from 6 of 20 serial patients using a light microscope (BX-51; Olympus, Tokyo, Japan) and by photography using a digital camera system (DP-70; Olympus).
Immunohistochemical Analysis
We analyzed hCLCA1, MUC5AC and IL-13R ␣ 1 subunit expression in cultured NHBE cells immunohistochemically. Human CLCA1 antibody immunostaining proceeded as described [16] . Takeda Chemical Industries provided a rabbit anti-hCLCA1 antibody [15, 16] . Briefl y, the N-terminal region of hCLCA1, corresponding to residues 22-124, was produced in Escherichia coli AD494 (DE3) as a hybrid protein fused to thioredoxin using the pET Trx Fusion System 32 (Novagen, Madison, Wisc., USA). The hCLCA1 fusion protein was purifi ed using the His Bind Purifi cation Kit (Novagen). The antibody directed against hCLCA1 was produced in rabbits injected with 0.7 mg of purifi ed fusion protein mixed with Freund's adjuvant (Sigma). The hCLCA1 antibody was produced by binding to hCLCA1, and then purifi ed by protein A and human CLCA4 column chromatography. Purifi ed hCLCA1 antibody specifi cally recognized hCLCA1 that was detected by Western blotting and immunohistochemistry at about 90 kDa in human small intestine protein and in Chinese hamster ovary cells. The antibody did not react to Gob-5 , rat Clca1 , or human CLCA4 expressed in Chinese hamster ovary cells. anti-mouse IgG (1: 200; Dako) for IL-13R ␣ 1 was added, and the sections were incubated for 30 min at room temperature. After 3 PBS washes to remove excess secondary antibody, antigen-antibody complexes were visualized using diaminobenzidine tetrahydrochloride (Wako).
Immunofl uorescent Confocal Microscopy Examination
Co-expressed hCLCA1 and MUC5AC in cultured NHBE cells were identifi ed using dual-immunofl uorescence techniques [26] and immunofl uorescent confocal microscopy. Because mucin granules tended to swell and coalesce in paraffi n-embedded fi xed specimens [27] , specimens were quick-frozen to circumstantially observe cells producing mucus. Cultured NHBE cells incubated with 10 ng/ml IL-13 for 14 days were embedded in Tissue-Tek OCT Compound (Sakura Finetechnical, Tokyo, Japan), rapidly frozen in liquid nitrogen and stored at -80 ° C.
The frozen samples were cut into 8-m slices using a cryostat at -20 ° C, mounted on slides and warmed to room temperature before fi xation in acetone at -4 ° C. The secondary antibodies were Cy3 donkey anti-rabbit IgG (1:500) for hCLCA1 and FITC goat anti-mouse IgG (1:200) for MUC5AC (Jackson ImmunoResearch Laboratories, West Grove, Pa., USA). After incubation with the primary and secondary antibodies for 1 h in the dark, the slides were rinsed with PBS three times, and then nuclei were stained with DAPI (Sigma) for 10 min in the dark. The slides were again rinsed with PBS three times and immersed in Fluorescent Mounting Medium ® (Dako, Carpinteria, Calif., USA). Coverslips were applied and the slides were stored at 4 ° C in the dark. All slides were examined by confocal laser scanning microscopy (TCS SP2 AOBS; Leica, Wetzlar, Germany) within 24 h of staining. Immunostaining was visualized with a blue diode, argon ion, and helium neon laser using 405, 488 and 543 laser lines, respectively.
Transmission Electron Microscopy
Electron-microscopic procedures have been described in detail elsewhere [28] . In brief, cells on porous fi lters were fi xed with glutaraldehyde/osmium tetroxide, dehydrated in a graded series of ethanol, substituted with propylene oxide and embedded in epoxy resin (Oken, Tokyo, Japan). Ultrathin sections were cut on an OmU3 ultramicrotome (Reichert-Jung, Vienna, Austria) at 0.1 m thickness and mounted on copper grids (Veco, Eerbeek, The Netherlands). The sections were observed with a JEM-1200EX transmission electron microscope (Jeol, Tokyo, Japan) at an accelerating voltage of 80 kV.
Western Blotting
Western blot analysis proceeded as described [29] . Briefl y, NHBE cells were cultured in medium containing 10 ng/ml of IL-13 on polycarbonate for 4, 7 or 14 days. Cultured NHBE cells were resuspended in lysis buffer [RIPA buffer; 50 m M Tris-HCl, 0.15 M sodium chloride, 0.1% sodium dodecylsulfate, 1% sodium deoxycholate, 1 m M phenylmethylsulfonylfl uoride (Wako), 1% Triton X-100 (Bio-Rad Laboratories, Calif., USA) and protease inhibitor cocktail (Nakalai Tesque, Kyoto, Japan)], fractured for 10 s using an ultrasonic cell disrupter (Taitec, Saitama, Japan) and then incubated for 5 min. Lysates were centrifuged at 20,000 g for 30 min and the supernatant was stored at -80 ° C. Harvested cell samples were lysed in RIPA buffer at 4 ° C for 15 min. For MUC5AC, cell lysates containing 50 g protein, determined using the method of Lowry et al. [30] , were denatured in reducing sample buffer and resolved by electrophoresis on 8% polyacrylamide gels for 150 min at 20 mA with ␣ 2 -macroglobulin (720 kDa; Sigma) as the molecular weight standard. Thereafter, samples were transferred to PVDF membranes in transfer buffer composed of 10 m M N-cyclohexyl-3-aminopropanesulfonic acid (Dojindo, Kumamoto, Japan) and 10% methanol for 90 min at 100 mA. The membranes were then blocked with 1% Tween-PBS and incubated with mouse monoclonal MUC5AC antibody (1: 100 Zymed, San Francisco, Calif., USA) for 24 h. For hCLCA1, cell lysates containing 50 g of protein were denatured in reducing sample buffer and resolved by electrophoresis on 8% polyacrylamide gels for 50 min at 75 mA. Thereafter, samples were transferred to PVDF membranes in
Statistical Analysis
All data are expressed as means 8 SEM. A two-way analysis of variance compared MUC5AC and hCLCA1 gene expression in the NHBE cells incubated with IL-13 and vehicle over time. The paired t test compared groups at specifi c times. One-way analysis of variance and Student's t test compared variables between vehicle-and IL-13-treated groups. Signifi cance was determined at p ! 0.05 (twotailed test).
Results
Relationships between IL-13 Concentration and GCH in Cultured NHBE Cells
When cultured using the air-liquid interface, NHBE cells developed a well-differentiated epithelial structure including ciliated, basal and secretory cells as reported previously [11, 19, 20] . The total number of epithelial cells, PAS-positive epithelial cells and goblet cells did not increase in the presence of 0.1 or 1 ng/ml IL-13 or vehicle (PBS) ( table 1 , fi g. 1 b). In contrast, the total number of epithelial cells increased in the presence of 10 ng/ml of IL-13 for 14 days ( table 1 ) . Likewise, incubation with IL-13 (10 ng/ml) for 14 days signifi cantly increased the number of PAS-positive epithelial cells and goblet cells ( table 1 , fi g. 1 c). PAS-positive cells and goblet cells were regularly arranged 14 days after adding IL-13 (10 ng/ml; fi g. 1 c). Furthermore, the total number of epithelial cells, and the numbers of PAS-positive and goblet cells significantly increased (data not shown), and PAS-positive cells were also regularly arranged 21 days after adding 10 ng/ ml IL-13 ( fi g. 1 d). The total number of epithelial cells, and the numbers of PAS-positive and goblet cells did not differ 14 and 21 days after exposure to 10 ng/ml IL-13 (data not shown). Thus 10 ng/ml of IL-13 induced the development of mucus-producing GCH.
The numbers of PAS-positive cells and goblet cells in the presence of 100 ng/ml of IL-13 also signifi cantly increased ( table 1 ) . Furthermore, the total cell number, and the numbers of PAS-positive epithelial cells and goblet cells did not signifi cantly differ after incubation with 100 and 10 ng/ml IL-13 (p 1 0.05). In contrast, PAS-positive cells were not always regularly arranged at the apical side of the cell layer 14 days after exposure to 100 ng/ml of IL-13 ( fi g. 1 e), and the arrangement was more haphazard with 100 ng/ml than with 10 ng/ml of IL-13 ( fi g. 1 e). These fi ndings indicated that 10 ng/ml of IL-13 were the optimal concentration for differentiation into goblet cells under our experimental conditions.
GCH Induced by IL-13 in Cultured NHBE Cells
Transmission electron microscopy revealed that GCH with secretory granules was induced by incubation with IL-13 (10 ng/ml) for 21 days ( fi g. 2 a). The number of goblet cells with mucin granules was increased in cell sheets incubated with IL-13 (10 ng/ml; fi g. 2 a) compared with those exposed to vehicle (PBS; fi g. 2 b). On the other hand, neither vehicle (PBS; fi g. 2 b) nor lower concentrations of IL-13 (0.1 and 1 ng/ml; data not shown) induced GCH. 
Gene Expression of hCLCA1 and MUC5AC Induced by IL-13 (10 ng/ml)
No hCLCA1 mRNA was expressed after 3 days of incubation with IL-13 (10 ng/ml), but it became detectable on day 5, increased thereafter and peaked on day 14 ( fi g. 3 a). The hCLCA1 mRNA expression was also increased after 21 days of exposure to IL-13 ( fi g. 3 a) whereas MUC5AC mRNA was expressed on day 3. The MUC5AC mRNA expression increased from day 3 and peaked on day 14 ( fi g. 3 b). The expression of MUC5AC mRNA was also increased after 21 days of exposure to IL-13 ( fi g. 3 b).
Protein Expression of hCLCA1 and MUC5AC
Immunohistochemical staining revealed that both hCLCA1 and MUC5AC proteins increased in NHBE cells cultured with IL-13 for 14 days at an air-liquid interface ( fi g. 4 ). Cells incubated with vehicle (PBS) were not stained with the antibody to hCLCA1 proteins ( fi g. 4 c). In contrast, cells were stained with antibody to MUC5AC ( fi g. 4 e). On the other hand, IL-13 increased the number of goblet cells stained with antibody for MUC5AC ( fi g. 4 f). In contrast, some goblet cells were stained with antibody for hCLCA1 ( fi g. 4 d, arrowheads), whereas others were negative or weakly stained with hCLCA1 ( fi g. 
Localization of hCLCA1 and MUC5AC
To obtain more information about the relationship between hCLCA1 and MUC5AC protein expression in goblet cells, we examined the localization of hCLCA1 and MUC5AC proteins using laser confocal microscopy. Both hCLCA1 and MUC5AC proteins were expressed only at goblet cells ( fi g. 5 a, b, d, e). MUC5AC proteins were detected in all goblet cells, whereas hCLCA1 proteins were expressed in some of them. MUC5AC-negative (and hCLCA1-positive) goblet cells were not observed in cells incubated with IL-13. MUC5AC proteins were localized at mucus granules, and hCLCA1 proteins were localized at the circumference of the MUC5AC proteins and surface of goblet cells ( fi g. 5 d, e).
Western Blot Analysis of hCLCA1 and MUC5AC Protein
The expression of hCLCA1 protein was not signifi cant after 4 days of IL-13 (10 ng/ml) exposure ( fi g. 6 a). In contrast, signifi cant amounts of hCLCA1 protein were expressed in the cells after 7 days of exposure, and the expression of hCLCA1 protein increased from day 7 to day 14 of IL-13 (10 ng/ml) exposure ( fi g. 6 a). On the other hand, MUC5AC protein was expressed after 4 days of incubation with IL-13 (10 ng/ml; fi g. 6 b). Furthermore, MUC5AC protein expression increased with time (from day 4 to day 14) of exposure to IL-13 (10 ng/ml; fi g. 6 b).
Effects of Chloride Channel Blockers on the Gene Expression of hCLCA1, MUC5AC and GCH
To estimate the activity of the inhibitor of chloride channel transport on the inhibition of IL-13-induced mRNA expression of hCLCA1, MUC5AC and GCH, cells were incubated with nifl umic acid (100 M ), a potent inhibitor of chloride secretion [31] (Calbiochem, Darmstadt, Germany). Our preliminary study showed that incubating the cells with nifl umic acid (100 M ) for more than 48 h induced damage such as cell detachment. Therefore, cells were incubated with nifl umic acid (100 M ) for 48 h from day 12 to day 14. Another study also used the same time of exposure and concentration of this reagent [31] . Nifl umic acid (100 M for 48 h) ob- viously reduced mRNA expression of MUC5AC and hCLCA1 induced by IL-13 (10 ng/ml). The expression of hCLCA1 mRNA in the cells incubated with nifl umic acid (100 M for 48 h) plus 10 ng/ml IL-13 (1.2 8 0.1%/ GAPDH, n = 3, p ! 0.01) was signifi cantly lower than that in cells incubated with 10 ng/ml IL-13 alone (15.8 8 4.7%/GAPDH, n = 3). Likewise, the expression of MUC5AC mRNA in cells incubated with nifl umic acid (100 M for 48 h) plus 10 ng/ml IL-13 (19.7 8 2.3%/ GAPDH, n = 3, p ! 0.01) was signifi cantly lower than that in cells treated with 10 ng/ml IL-13 alone (167.5 8 23.7%/ GAPDH, n = 3). Furthermore, incubation with 10 ng/ml IL-13 significantly increased the number of goblet cells ( fi g. 7 a). In contrast, nifl umic acid (100 M for 48 h) signifi cantly reduced the number of goblet cells induced by IL-13 ( fi g. 7 b).
Effects of Antibody to the IL-13R ␣ 1 Subunit on IL-13
Because a heterodimer of the IL-4R ␣ and IL-13R ␣ 1 subunits is associated with the activity of IL-13 in airway epithelial cells [5] , we performed neutralization studies against IL-13R ␣ 1 and IL-4R ␣ . IL-13 (10 ng/ml) and either anti IL-13R ␣ 1 (10 g/ml) or anti IL-4R ␣ (100 ng/ml) [32] antibodies (R & D Systems, Minneapolis, Minn., USA) were incubated with the cells for 14 days. We initially found that 10 g/ml of anti-IL-13R ␣ 1 reduced the number of goblet cells after exposure to IL-13 (10 ng/ml), (10 ng/ml) was similar to that in cells incubated with vehicle (PBS; fi g. 9 a, b). In the absence of the fi rst antibody (anti-IL-13R ␣ 1 antibody), no positive staining for IL-13R ␣ 1 was evident after incubation with IL-13 (10 ng/ml; fi g. 9 c).
Effects of IL-13 on IL-13 Receptor Expression
Discussion
The present study showed that human recombinant IL-13 directly induced the gene and protein expression of MUC5AC and hCLCA1 in well-differentiated NHBE cells in vitro, and that these cells also differentiated into goblet cells and became hyperplastic. These conclusions were based on the fi ndings that exposure to IL-13 for 14 days increased the total number of epithelial cells, the numbers of PAS-stained epithelial cells and goblet cells, and mRNA and protein expression of hCLCA1 and MUC5AC. Numbers of PAS-positive cells and of goblet cells were also increased 21 days after incubation with IL-13. Transmission electron microscopy revealed increased numbers of goblet cells with secretory granules 21 days after exposure to IL-13. Nifl umic acid, a chloride channel inhibitor, reduced mRNA expression of hCLCA1 and MUC5AC, and the number of goblet cells after exposure to IL-13. NHBE cells expressed IL-13R ␣ 1 , and an antibody to IL-13 R ␣ 1 also reduced the number of goblet cells induced by IL-13.
Peak gene induction of hCLCA1 and MUC5AC was evident 14 days after exposure to IL-13. Therefore, gene expression of hCLCA1 and MUC5AC might be induced by IL-13. GCH was evident after 14 and 21 days of exposure to IL-13. Furthermore, the chloride channel inhibitor nifl umic acid reduced mRNA expression of hCLCA1 and MUC5AC, and the number of goblet cells after exposure to IL-13. These fi ndings suggest that the gene expression of hCLCA1 and MUC5AC is associated with the protein expression of hCLCA1, MUC5AC and GCH, as described [18] .
On the other hand, immunohistochemical analysis showed that hCLCA1 protein was distributed in some goblet cells, while MUC5AC protein was expressed in all goblet cells. Laser confocal microscopy showed that both hCLCA1 and MUC5AC proteins were expressed only at sites of goblet cells. MUC5AC proteins were localized at mucus granules, and hCLCA1 proteins were localized at the circumference of the MUC5AC proteins and goblet cell surface. Although hCLCA1 is overexpressed in the airway epithelium of asthma patients [16] , Robichaud et al. [33] reported that hCLCA1 is not primarily essential for mucus overproduction. Therefore, mechanisms unrelated to hCLCA1 might also be associated with GCH induced by IL-13.
The MUC genes encode the protein backbones of large, viscoelastic, highly glycosylated macromolecules called mucins that comprise the major macromolecular components of airway mucus [2] . Sixteen genes encoding human mucins have been identifi ed, including the dominant MUC5AC gene that is expressed in airway goblet cells [2] . In bronchial biopsy specimens from asthmatics, MUC5AC expression is ϳ 60% increased compared to non-asthmatic individuals [34] .
On the other hand, the novel CLCA family of proteins mediates Ca 2+ -activated Cl conductance [14] [15] [16] . The hCLCA family might play an important role in fl uid and electrolyte transport, as well as in mucus secretion in the digestive tract and in the mucus overproduction associated with GCH in the airways of patients with asthma and COPD [14] [15] [16] . The development of airway hyperresponsiveness is closely associated with hCLCA1 in the mouse model of asthma [15] . Zhou et al. [31] have demonstrated that expression of the transfected hCLCA1 gene in NCI-H292 cells induces mucin production and that nifl umic acid, a blocker of the Cl effl ux, inhibits MUC5AC production in these cells. They also demonstrated that nifl umic acid reduces airway infl ammation, goblet cell metaplasia and mucus overproduction with the upregulation of mCLCA3 (that corresponds to hCLCA1) in mice intranasally instilled with Aspergillus fumigatus extract antigen [31] . However, whether the Th2 cytokines, including IL-13, can directly induce hCLCA1 expression in cultured NHBE cells was unknown, although IL-13 and IL-4 directly induce MUC5AC gene expression and mucus production in cultured airway epithelial cells [11, 35, 36] . Here, we demonstrated that IL-13 induced the gene and protein expression of hCLCA1 as well as the expression of MUC5AC together with the development of GCH in cultured NHBE cells. Leverkoehne and Gruber [37] found occasional mCLCA3 protein expression in the mucous layer lining the intestinal lumen in both the small and large intestines. The expression of hCLCA1 protein in some goblet cells in the present study is consistent with their fi ndings.
The IL-13 receptor was thought to induce mucin production via IL-13R ␣ 1 [5] or EGF receptor (EGFR) [38] . The expression of IL-13R ␣ 1 in cultured NHBE cells was consistent with the fi ndings in normal and asthmatic bronchial epithelial cells [39] , and in cells in the presence or absence of IL-13 [40] . Furthermore, GCH was reduced by the neutralization of IL-13R ␣ 1 . Neutralization of IL-4R ␣ , which is also associated with the activity of IL-13
in airway epithelial cells [5] , reduced GCH after the cells were exposed to IL-13. IL-13R ␣ 1 and IL-4R ␣ might be associated with IL-13-induced mucus overproduction in cultured NHBE cells. On the other hand, EGF as well as stimulation of the EGFR and EGFR-tyrosine kinase by tumor necrosis factor-␣ or transforming growth factor-␣ [21] may play key roles in epithelial differentiation [20] , MUC5AC expression and mucin production [21] in rat and human airways. Shim et al. [38] reported that IL-13 induces mucin production by stimulating EGFR and by activating neutrophils. Further studies are needed to confi rm the role of EGFR in the IL-13-induced GCH.
Western blotting revealed hCLCA1 protein expression in the cells 7 days after exposure to IL-13, and this increased until day14, although hCLCA1 protein was not evident 4 days after exposure. In contrast, MUC5AC protein was expressed 4 days after exposure to IL-13. MUC5AC protein expression increased from day 4 until day 14. On the other hand, mRNA expression of hCLCA1 did not increase after 3 days of exposure to IL-13. Increases in hCLCA1 mRNA expression were signifi cant from day 5 after exposure to IL-13. In contrast, increases in MUC5AC mRNA expression were significant 3 days after exposure to IL-13. IL-13 increased hCLCA1 mRNA from day 5 to day 14, and MUC5AC mRNA from day 3 to day 14. Thus, the time course changes in protein expression of hCLCA1 and MUC5AC were similar to those of hCLCA1 and MUC5AC mRNA.
In summary, IL-13 induced gene and protein expression of hCLCA1 and MUC5AC, and induced GCH in well-differentiated NHBE cells cultured at an air-liquid interface. The protein expression of hCLCA1 and MUC5AC peaked 14 days after exposure to IL-13, and GCH was observed at 14 and 21 days after exposure to IL-13. Nifl umic acid, a chloride channel inhibitor, reduced the mRNA expression of hCLCA1 and MUC5AC, and inhibited GCH after exposure to IL-13. Cultured NHBE cells expressed IL-13R ␣ 1 , and an antibody to IL-13R ␣ 1 reduced the number of goblet cells after exposure to IL-13. These fi ndings suggest that IL-13 induces hCLCA1 through the pathway of MUC5AC expression, and that hCLCA1 might play an important role in mucus overproduction and GCH.
